Archives

FAIRFAX, Va. -- The American Society for Therapeutic Radiology and Oncology has published an updated version of its brochure Radiation Therapy for Gynecologic Cancers. The brochure provides women coping with a gynecologic cancer useful information on the different types of radiation therapy and their treatment options, as well as new information on the potential side effects and how to care for themselves while undergoing treatment.

The human papillomavirus (HPV) has been implicated as a cause of cervical cancer in women, but there's another devastating form of cancer also linked to HPV infection head and neck cancer and almost no one is talking about it. Right now I think the public and most physicians have no idea that HPV relates to head and neck cancer, said Dell Yarbrough, M.D., Vanderbilt-Ingram Cancer Center surgical oncologist. In cancers of the oropharynx, which includes the tonsils, the base of the tongue, and part of the throat, about half of those tumors are HPV-positive.

WASHINGTON -- U.S. researchers and women's health advocates want more federal funding for research on women who get lung cancer. Meeting with lawmakers on Capitol Hill last week, Phyllis Greenberger, head of the Society for Women's Health Research, said new research shows differences in susceptibility, progression and responsiveness to treatment in lung cancer between women and men. The Lung Cancer Alliance said lung cancer research is severely underfunded. The disease kills more than 70,800 women a year, 30,000 more than breast cancer.

WASHINGTON -- Clinical trials are critical for physicians and researchers to identify the best, most effective ways to treat cancer and other diseases. However, studies have shown that many people are often unaware of clinical trial opportunities available to them after diagnosis. In recognition of Prostate Cancer Awareness Month (PCAM), the National Prostate Cancer Coalition (NPCC) is raising awareness of clinical trials as a treatment option for men who have been diagnosed with the disease.

EVERGREEN PARK, Ill. -- In 2007, more than 218,000 American men will be diagnosed with prostate cancer, and more than 27,000 men will die from the disease, according to the American Cancer Society. While it is estimated that one man in six will suffer from prostate cancer in his lifetime, only one man in 34 will die from it. The earlier the disease is diagnosed and treated, the more likely it is for patients to survive and remain disease-free.

BOSTON -- - About a third of American adults take some type of multivitamin on a regular basis. In nearly every case, the goal is better health, even though there is no firm evidence to support this hope. The absence of benefit is one thing, but the presence of harm is another: A 2007 report in the Journal of the National Cancer Institute concluded that there was an increased prostate cancer risk among men using multivitamins, reports the October 2007 issue of Harvard Men's Health Watch.

TOLEDO, OH -- Gene Express, Inc. today announced that its molecular diagnostic test for lung cancer has demonstrated high levels of accuracy in a recent study presented at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development. James C. Willey, M.D., Founder, Inventor and Chief Science and Medical Consultant to Gene Express, and his colleagues from the University of Toledo, identified a panel of 15 genes that could serve to predict cancer. According to Dr.

WASHINGTON -- U.S. researchers and women's health advocates want more federal funding for research on women who get lung cancer. Meeting with lawmakers on Capitol Hill last week, Phyllis Greenberger, head of the Society for Women's Health Research, said new research shows differences in susceptibility, progression and responsiveness to treatment in lung cancer between women and men. The Lung Cancer Alliance said lung cancer research is severely underfunded. The disease kills more than 70,800 women a year, 30,000 more than breast cancer.

CHICAGO -- In a development that could greatly enhance doctors' ability to tailor cancer treatment to those who need it most, researchers have identified a tiny molecule that makes breast cancer cells spread to other organs. More than 200,000 U.S. women a year are diagnosed with breast cancer, and virtually all of them are treated with some combination of surgery, drugs and radiation. Scientists have known for years that most don't need such aggressive treatment, but so far medicine cannot tell for sure which tumors are life-threatening.

What exemplifies being a man more emphatically than supporting a loved one battling breast cancer?